Episode Details

Back to Episodes

Variation in Endpoints for FDA Approved Migraine Therapies

Published 2 years, 4 months ago

Description

Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".

Show References: https://n.neurology.org/content/101/10/e989

https://directory.libsyn.com/episode/index/id/27962343

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.